Zevin Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.8M | Sell |
81,849
-673
| -0.8% | -$149K | 2.46% | 11 |
|
|
2025
Q4 | $18.9M | Sell |
82,522
-4,457
| -5% | -$1.02M | 2.53% | 13 |
|
|
2025
Q3 | $20.1M | Sell |
86,979
-4,663
| -5% | -$950K | 2.93% | 11 |
|
|
2025
Q2 | $17M | Buy |
91,642
+10,144
| +12% | +$1.89M | 2.45% | 15 |
|
|
2025
Q1 | $17.1M | Sell |
81,498
-1,193
| -1% | -$232K | 2.71% | 13 |
|
|
2024
Q4 | $14.7M | Buy |
82,691
+6,668
| +9% | +$1.23M | 2.16% | 17 |
|
|
2024
Q3 | $15M | Sell |
76,023
-1,268
| -2% | -$237K | 2.32% | 17 |
|
|
2024
Q2 | $13.3M | Sell |
77,291
-4,528
| -6% | -$750K | 2.15% | 18 |
|
|
2024
Q1 | $14.9M | Sell |
81,819
-799
| -1% | -$138K | 2.48% | 17 |
|
|
2023
Q4 | $12.8M | Sell |
82,618
-347
| -0.4% | -$50.6K | 2.3% | 19 |
|
|
2023
Q3 | $12.4M | Buy |
82,965
+1,996
| +2% | +$293K | 2.49% | 17 |
|
|
2023
Q2 | $10.9M | Buy |
80,969
+479
| +0.6% | +$70.2K | 2.19% | 21 |
|
|
2023
Q1 | $12.8M | Sell |
80,490
-2,328
| -3% | -$356K | 2.62% | 16 |
|
|
2022
Q4 | $13.4M | Sell |
82,818
-1,749
| -2% | -$268K | 2.91% | 14 |
|
|
2022
Q3 | $11.3M | Buy |
84,567
+2,114
| +3% | +$303K | 2.68% | 16 |
|
|
2022
Q2 | $12.6M | Sell |
82,453
-3,908
| -5% | -$597K | 2.85% | 15 |
|
|
2022
Q1 | $14M | Sell |
86,361
-4,475
| -5% | -$650K | 2.68% | 15 |
|
|
2021
Q4 | $12.3M | Buy |
90,836
+1,137
| +1% | +$134K | 2.22% | 17 |
|
|
2021
Q3 | $9.68M | Buy |
89,699
+6,603
| +8% | +$754K | 1.84% | 20 |
|
|
2021
Q2 | $9.36M | Buy |
83,096
+2,600
| +3% | +$293K | 1.86% | 21 |
|
|
2021
Q1 | $8.71M | Buy |
80,496
+2,434
| +3% | +$260K | 1.93% | 22 |
|
|
2020
Q4 | $8.36M | Buy |
78,062
+2,965
| +4% | +$285K | 1.96% | 19 |
|
|
2020
Q3 | $6.58M | Buy |
75,097
+2,126
| +3% | +$200K | 1.79% | 19 |
|
|
2020
Q2 | $7.16M | Buy |
72,971
+227
| +0.3% | +$20K | 2.18% | 18 |
|
|
2020
Q1 | $5.54M | Buy |
72,744
+2,999
| +4% | +$255K | 2.06% | 19 |
|
|
2019
Q4 | $6.17M | Buy |
69,745
+354
| +0.5% | +$29.4K | 1.89% | 20 |
|
|
2019
Q3 | $5.25M | Buy |
69,391
+871
| +1% | +$59.7K | 1.69% | 22 |
|
|
2019
Q2 | $4.98M | Buy |
68,520
+279
| +0.4% | +$21.9K | 1.6% | 23 |
|
|
2019
Q1 | $5.5M | Sell |
68,241
-165
| -0.2% | -$13.5K | 1.8% | 22 |
|
|
2018
Q4 | $6.31M | Sell |
68,406
-1,782
| -3% | -$157K | 2.29% | 14 |
|
|
2018
Q3 | $6.64M | Sell |
70,188
-1,965
| -3% | -$186K | 1.94% | 20 |
|
|
2018
Q2 | $6.68M | Sell |
72,153
-12,892
| -15% | -$1.26M | 2% | 17 |
|
|
2018
Q1 | $8.05M | Sell |
85,045
-20,180
| -19% | -$2.22M | 2.09% | 18 |
|
|
2017
Q4 | $10.2M | Sell |
105,225
-4,203
| -4% | -$396K | 2.31% | 12 |
|
|
2017
Q3 | $9.72M | Buy |
109,428
+924
| +0.9% | +$70.3K | 2.28% | 12 |
|
|
2017
Q2 | $7.87M | Sell |
108,504
-4,440
| -4% | -$298K | 1.99% | 15 |
|
|
2017
Q1 | $7.36M | Sell |
112,944
-12,239
| -10% | -$769K | 1.86% | 16 |
|
|
2016
Q4 | $7.84M | Sell |
125,183
-26,993
| -18% | -$1.65M | 2.05% | 14 |
|
|
2016
Q3 | $9.6M | Sell |
152,176
-20,483
| -12% | -$1.33M | 3.1% | 6 |
|
|
2016
Q2 | $10.7M | Buy |
172,659
+1,388
| +0.8% | +$84.6K | 2.97% | 8 |
|
|
2016
Q1 | $9.78M | Sell |
171,271
-113,210
| -40% | -$6.31M | 2.77% | 8 |
|
|
2015
Q4 | $16.9M | Buy |
284,481
+208,435
| +274% | +$12M | 4.44% | 4 |
|
|
2015
Q3 | $4.14M | Sell |
76,046
-580
| -0.8% | -$37.8K | 1.21% | 25 |
|
|
2015
Q2 | $5.15M | Buy |
76,626
+540
| +0.7% | +$35.3K | 1.37% | 26 |
|
|
2015
Q1 | $4.45M | Buy |
76,086
+8,100
| +12% | +$489K | 1.23% | 30 |
|
|
2014
Q4 | $4.45M | Sell |
67,986
-8,530
| -11% | -$538K | 1.25% | 27 |
|
|
2014
Q3 | $4.42M | Sell |
76,516
-33
| -0% | -$1.83K | 1.29% | 28 |
|
|
2014
Q2 | $4.32M | Buy |
76,549
+13,425
| +21% | +$704K | 1.27% | 25 |
|
|
2014
Q1 | $3.25M | Sell |
63,124
-37,984
| -38% | -$1.92M | 1.02% | 35 |
|
|
2013
Q4 | $5.34M | Buy |
101,108
+1,682
| +2% | +$82.7K | 1.51% | 21 |
|
|
2013
Q3 | $4.45M | Buy |
+99,426
| New | +$4.41M | 1.36% | 24 |
|
Other funds holding ABBV
VCM
VPM
Zevin Asset Management's ABBV Position: Q1 2026 in Review
Zevin Asset Management reduced its AbbVie (ABBV) stake by 0.82% in Q1 2026, selling an estimated $149K and leaving 81,849 shares worth $17.8M. The position accounts for 2.46% of the portfolio, ranked #11.
Zevin Asset Management first reported a position in ABBV in Q3 2013 and has held it in 51 quarters since. The position peaked at $20.1M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Zevin Asset Management held 81,849 shares of AbbVie worth $17.8M as of Q1 2026.
- Zevin Asset Management sold 673 AbbVie shares in Q1 2026, an estimated $149K.
- AbbVie made up 2.46% of Zevin Asset Management's portfolio in Q1 2026, its #11 holding.
- Zevin Asset Management first reported a position in AbbVie in Q3 2013 and has held it in 51 quarters since.
- Zevin Asset Management's AbbVie position peaked at $20.1M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Zevin Asset Management's 13F filing for Q1 2026, filed 7 May 2026.